Literature DB >> 18585503

Exercise capacity and biventricular function in adult patients with repaired tetralogy of Fallot.

Ahmed Samman1, Markus Schwerzmann, Olga H Balint, David Tanous, Andrew Redington, John Granton, Samuel C Siu, Candice K Silversides.   

Abstract

BACKGROUND: Adult patients with repaired tetralogy of Fallot (rTOF) often have diminished exercise capacity. The primary objective of this study was to examine whether abnormalities of biventricular function play a role in exercise limitation in patients with rTOF.
METHODS: This was a retrospective review of 99 adult patients with rTOF. Right ventricular (RV) and left ventricular (LV) function were assessed echocardiographically using the myocardial performance index (MPI). Maximal oxygen consumption (VO(2) Max) was measured during a level 1 cardiopulmonary exercise test.
RESULTS: The mean age of the cohort was 34 +/- 11 years (50% females). Although most of the patients reported good functional capacity, the peak Vo(2)max was decreased at 22 +/- 6 mL/kg per minute (66% +/- 13% predicted Vo(2)max for age and sex). The mean RV and LV MPI were 0.30 +/- 0.07 and 0.42 +/- 0.09, respectively. In the multivariate model, higher RV MPI (P = .04) and LV MPI (P = .005) values, representing impaired ventricular function, were associated with diminished Vo(2)max. There was a significant correlation between the RV and LV MPI (r = 0.54, P = .001).
CONCLUSIONS: Impairment of RV and LV function, as measured by MPI, is associated with diminished exercise capacity in patients with repaired tetralogy of Fallot. Furthermore, there is a linear relationship between the RV and LV function suggesting that ventricular interactions are contributing to the limited exercise capacity in this group of patients. Strategies aimed at preserving biventricular function or improving adverse ventricular interactions could help to improve functional capacity in these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18585503     DOI: 10.1016/j.ahj.2008.02.005

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Habitual exercise correlates with exercise performance in patients with conotruncal abnormalities.

Authors:  Michael L O'Byrne; Laura Mercer-Rosa; Eitan Ingall; Michael G McBride; Stephen Paridon; Elizabeth Goldmuntz
Journal:  Pediatr Cardiol       Date:  2012-10-27       Impact factor: 1.655

Review 2.  The Role of Cardiopulmonary Exercise Testing for Decision Making in Patients with Repaired Tetralogy of Fallot.

Authors:  Frederic Dallaire; Rachel M Wald; Ariane Marelli
Journal:  Pediatr Cardiol       Date:  2017-06-16       Impact factor: 1.655

3.  Longitudinal exercise capacity of patients with repaired tetralogy of fallot.

Authors:  Alaina K Kipps; Dionne A Graham; David M Harrild; Erik Lewis; Andrew J Powell; Jonathan Rhodes
Journal:  Am J Cardiol       Date:  2011-04-29       Impact factor: 2.778

4.  Assessing Late Cardiopulmonary Function in Patients with Repaired Tetralogy of Fallot Using Exercise Cardiopulmonary Function Test and Cardiac Magnetic Resonance.

Authors:  Ming-Chun Yang; Chun-An Chen; Hsin-Hui Chiu; Ssu-Yuan Chen; Jou-Kou Wang; Ming-Tai Lin; Shuenn-Nan Chiu; Chun-Wei Lu; Shu-Chien Huang; Mei-Hwan Wu
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

5.  Assessment of exercise testing after repair of tetralogy of fallot.

Authors:  A A Kotby; H M Elnabawy; W M El-Guindy; R F Abd Elaziz
Journal:  ISRN Pediatr       Date:  2012-09-02

6.  Exercise testing and prescription in patients with congenital heart disease.

Authors:  A D J Ten Harkel; T Takken
Journal:  Int J Pediatr       Date:  2010-09-06

7.  Cardiopulmonary Exercise Testing in Repaired Tetralogy of Fallot: Multiparametric Overview and Correlation with Cardiac Magnetic Resonance and Physical Activity Level.

Authors:  Benedetta Leonardi; Federica Gentili; Marco Alfonso Perrone; Fabrizio Sollazzo; Lucia Cocomello; Stefani Silva Kikina; Rachel M Wald; Vincenzo Palmieri; Aurelio Secinaro; Maria Giulia Gagliardi; Attilio Parisi; Attilio Turchetta; Lorenzo Galletti; Massimiliano Bianco; Fabrizio Drago
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.